Explore skinny labelling & obviousness in Canada and Australia

If you are an intellectual property (IP) owner, a litigator or an in-house legal professional managing IP litigation in multiple jurisdictions, don’t miss this exclusive discussion with leading IP lawyers from Canada and Australia.

Discussing the nuances and differences in the application of strategies and pharmaceutical patent litigation across jurisdictions are four IP experts from IPH Group’s Smart & Biggar in Canada and Spruson & Ferguson in Australia.

Speakers:

• Katrina Crooks, Principal, Spruson & Ferguson
• Sheldon Hamilton, Principal, Smart & Biggar
• Duncan Longstaff, Principal, Spruson & Ferguson
• Urszula Wojtyra, Principal, Smart & Biggar
• Brandon Heard (Moderator US/Canada), Senior Associate, Smart & Biggar
• Chen Li (Moderator UK/EU), Associate, Smart & Biggar

Topics will include:

• Skinny labelling: understand how skinny labelling strategies are likely to be assessed and how different claim structures can make a difference.
• Obviousness: explore how this key patent issue is treated differently in each jurisdiction and its relevance for evidence preparation.

Date & Time:

This one-hour webinar is offered at two different times to accommodate various time zones. If neither option works for you, please register so that a replay can be sent to you after the webinar.

1. [UK and Europe] Thursday, September 12, 2024 | 12 PM (GMT) | 1 PM (CEST)
2. [US and Canada] Wednesday, September 18, 2024 | 2 PM (PDT) | 5 PM (EDT)